[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
About the Journal
Editorial Board
Keywords
For Authors::
Aims and Scope
Call for Papers
Submission Instructions
For Reviewers::
Referee page
Subscription::
Subscription Form
News & Events::
Journal News
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE
:: Volume 23, Issue 2 (5-2025) ::
Int J Radiat Res 2025, 23(2): 329-334 Back to browse issues page
Effectiveness of levonorgestrel-based intrauterine insemination system therapy combined with hysteroscopic electrosurgery and radiotherapy in the treatment of highly differentiated endometrial cancer
P. Lian , H. Xu , S. Liu , H. Qian
Department of Gynecology, Hubei Geological Hospital, Wuhan, Hubei 430000, China , medicalsciences.paper@gmail.com
Abstract:   (355 Views)
Background: Exploring the efficacy of levonorgestrel intrauterine contraceptive system combined with hysteroscopic resection for the treatment of early and highly differentiated endometrial cancer in young patients and its impact on reproductive function. Materials and Methods: According to the grouping method, the patients were divided into a single hysteroscopy group and a combined progesterone group, with 77 patients in each group. Among them, the single hysteroscopy group received hysteroscopic resection surgery, while the combined progesterone group received levonorgestrel intrauterine contraceptive system treatment on hysteroscopic resection surgery beside radiation. Results: After treatment, endometrial thickness, uterine volume and myoma volume were lower in the combined treatment group than in the intrauterine sustained release group (P<0.05); after treatment, estradiol, FSH and progesterone levels were lower in the combined treatment group compared with the intrauterine sustained release group (P<0.05); after treatment, Hb and VEGF levels were lower in the combined treatment group compared with the intrauterine sustained release group (P < 0.05); after treatment, compared with the intrauterine sustained release group, Hb and VEGF levels were lower in the combined treatment group (P<0.05);Compared with the intrauterine sustained release group, the dysmenorrhea score and CA125 expression level in the combined treatment group were lower (P<0.05); compared with the intrauterine sustained release group, the effective rate of the combined treatment group was higher (P<0.05). Conclusion: The application of mifepristone combined with levonorgestrel intrauterine sustained release system in the treatment of patients with uterine fibroids can effectively improve the symptoms of patients, alleviate clinical symptoms, alleviate dysmenorrhea, effectively inhibit the further development of the disease, reduce the expression level of CA125, improve the prognosis of patients, and have a significant therapeutic effect.
Keywords: Endometrial cancer, levonorgestrel intrauterine contraceptive system, hysteroscopic electrocision, fertility function, radiotherapy.
Full-Text [PDF 574 kb]   (95 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
References
1. Lu YY, Yang F, Zheng Y (2021) Research progress and prospect on the application of sentinel lymph nodes in endometrial cancer. Chinese Journal of Cancer, 31(10): 944-948.
2. Laganà AS, Franchi MP, Garzon S (2022) Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women. Medicina (Kaunas), 58(9): 1256. [DOI:10.3390/medicina58091256]
3. Mo JS, Su BL, Liang XM, et al. (2019) Study on the efficacy and recurrence of hysteroscopic electrosurgery and radiotherapy combined with progesterone in the treatment of young patients with early progesterone receptor-positive endometrial cancer. Chinese Journal of Practical Medicine, 46(12): 58-60.
4. Zhang YX, Duan GT, Meng P (2020) Observation on the efficacy of conservative hysteroscopic surgery combined with progestin in the treatment of early endometrial cancer. Journal of Clinical and Experimental Medicine, 19(12): 1339-1341.
5. Fu LY, Duan SY, Wan SZ (2008) Application of visual analog scoring method in patient satisfaction survey. China Nursing Management, 8(9): 68-69.
6. Li J, Wu S, Zhang Z (2022) Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism. Lab Invest, 102(12): 1335-1345. [DOI:10.1038/s41374-022-00816-5]
7. Li AL, Hou QX, Lei WL (2020) Effect of hysteroscopic electrodesiccation combined with hormonal therapy for endometrial cancer on patients' serum PLGF level, disease progression and recurrence. Journal of Practical Cancer, 35(9): 1449-1455.
8. Ye XY (2021) Effect of mifepristone combined with hysteroscopic electrosurgery and radiotherapy on fertility function of endometrial cancer patients. China Maternal and Child Health Care, 36(19): 4618-4620.
9. Zhao YR, Xu YX, Zhou Y (2022) Effect of goserelin combined with hysteroscopic electrosurgery and radiotherapy on postoperative disease remission and recurrence in patients with early endometrial cancer. China Drugs and Clinics, 22(4): 358-360.
10. Li S, Yang JM, Sun L, et al. (2021) Clinical efficacy and conservation function of hysteroscopic laparoscopic surgery combined with high-efficiency progestin in the treatment of endometrial cancer patients. Cancer Progress, 19(5)519-529.
11. Aizetz M (2017) Observation on therapeutic effect of hysteroscopic electrosurgery and radiotherapy with biochemical soup plus flavor in the treatment of early endometrial cancer. Modern Journal of Integrative Chinese and Western Medicine, 26(2): 202-225.
12. Liu SM, Meng B, Meng YG (2019) Meta-analysis of the efficacy of hysteroscopic electrodesiccation combined with mannuelle in the treatment of early endometrial cancer with preservation of reproductive function. Journal of Guangxi Medical University, 36(6): 898-904.
13. Ma Z, Tian CH, Yang MF, et al. (2021) Effects of miR-21 antagonist and levonorgestrel on proliferation and apoptosis of endometrial cancer lshikawa cells. Journal of Ningxia Medical University, 43(11):1109-1124.
14. Xiao XC, Zhou X, Wang YX (2021) Efficacy of gonadotropin-releasing hormone combined with levonorgestrel intrauterine system for the treatment of patients with early-stage highly differentiated endometrial cancer and the impact on pregnancy outcome. Cancer Progress, 19(20): 2129-2144.
15. Emons G and Gründker C (2021) The role of gonadotropin-releasing hormone (GnRH) in endometrial cancer. Cells, 10(2): 292. [DOI:10.3390/cells10020292]
16. Yang YF and Zhang J (2021) Observation on the safety of endometrial cancer staging surgery in patients with endometrial cancer after percutaneous coronary intervention with antiplatelet therapy. Chinese Medicine, 16(6): 900-904.
17. Guo YS, Feng RL, Weng YH, et al. (2018) Study on changes in serum VEGF and CRP levels and correlation in endometrial cancer patients with different clinical stages. Journal of Chengdu Medical College, 13(1): 68-70,105.
18. Su LZ, Meng J, Jin J, et al. (2022) Expression of miR-155, HE4, and VEGF in endometrial cancer and its relationship with patient prognosis. Laboratory Medicine and Clinics, 19(22): 3062-3068.
19. Zhang X, Sang CM, Tian SX, et al. (2021) Effect of hysteroscopic electrosurgery and radiotherapy and drug treatment for focal early endometrial cancer. Journal of Qingdao University, 57(1): 39-42.
20. Li Y, Mu KK, Dong YH, et al. (2019) Study on the value of CEA, CA19-9, CA125, HE4 and menopausal ROMA value determination for clinical staging of endometrial cancer. International Journal of Laboratory Medicine, 40(3): 304-307.
21. Leombroni M, Dessole M, Lucidi A (2022) Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol, 273: 90-97. [DOI:10.1016/j.ejogrb.2022.04.019]
22. Dai J and Yang B (2021) Current status and problems of fertility preservation treatment for endometrial cancer. Sichuan Medicine, 42(3): 313-317.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Lian P, Xu H, Liu S, Qian H. Effectiveness of levonorgestrel-based intrauterine insemination system therapy combined with hysteroscopic electrosurgery and radiotherapy in the treatment of highly differentiated endometrial cancer. Int J Radiat Res 2025; 23 (2) :329-334
URL: http://ijrr.com/article-1-6313-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 2 (5-2025) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.03 seconds with 48 queries by YEKTAWEB 4714